je.st
news
Tag: drug
FDA Accepts OPKO's New Drug Application For Rayaldee
2015-07-30 02:52:44| drugdiscoveryonline News Articles
OPKO Health, Inc. recently announced that the U.S. Food and Drug Administration (FDA) has accepted for review OPKO’s New Drug Application (NDA) for calcifediol modified-release capsules (proposed trade name, Rayaldee).
Tags: application
drug
accepts
fda
Mets reliever Mejia banned for year for positive drug test
2015-07-29 06:22:33| Food - Topix.net
The M... The son and ex-daughter-in-law of late black golf pioneer Charlie Sifford were indicted Tuesday on charges they stole more than $1 million from him. The son and ex-daughter-in-law of late black golf pioneer Charlie Sifford were indicted Tuesday on charges they stole more than $1 million from him.
Mets reliever Mejia banned for year for positive drug test
2015-07-29 03:37:24| Beverages - Topix.net
The M... The son and ex-daughter-in-law of late black golf pioneer Charlie Sifford were indicted Tuesday on charges they stole more than $1 million from him. The son and ex-daughter-in-law of late black golf pioneer Charlie Sifford were indicted Tuesday on charges they stole more than $1 million from him.
Merck Announces U.S. Food and Drug Administration Acceptance of New Drug Application for Grazoprevir/Elbasvir, an Investigational Therapy for Treatment of Chronic Hepatitis C Genotypes 1, 4 and 6 Infection
2015-07-28 12:30:00| Merck.com - Research & Development News
Dateline City: KENILWORTH, N.J. Company Granted FDA Priority Review with Target Action Date of January 28, 2016 KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Language: English Contact: MerckMedia:Doris Li, (908) 246-5701Sarra Herzog, (201) 669-6570orInvestor:Joe Romanelli, (908) 740-1986Justin Holko, (908) 740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: and
food
application
administration
Allergan generic drug firm bought for $40.5B
2015-07-28 00:44:29| Biotech - Topix.net
Israel's Teva Pharmaceutical Industries Ltd. said Monday it is purchasing Dublin-based Allergan PLC's generic pharmaceuticals business for $40.5 billion, in what Israeli analysts called the largest-ever acquisition by an Israeli company. Statements from both companies say the deal will see Allergan receive $33.75 billion in cash and shares of Teva valued Monday at $6.75 billion.
Tags: firm
drug
bought
generic
Sites : [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] next »